12 Best Tempus Alternatives & Competitors (2026)

Epic Systems supplies the dominant EHR platform with embedded analytics and scheduling modules. Its strength is deep clinical documentation and interoperability, yet it does not itself deliver AI-driven visit-capacity increases or operate care networks. Hospitals already on Epic may layer Scope AI-like tools on top rather than switch entirely when the priority is access expansion over record-keeping.

IQVIA supplies global real-world evidence datasets spanning imaging, claims, and EHR records with regulatory consulting services. It offers unmatched international coverage. Compared with Segmed, IQVIA’s imaging depth is lower and contracts are typically larger, suiting enterprise evidence programs rather than focused AI R&D teams needing rapid radiology cohort access.

Azure Health Data Services offers FHIR and DICOM APIs with compliance tooling for healthcare workloads. It provides scalable storage and analytics. Versus Segmed it supplies no curated imaging datasets, requiring customers to ingest and annotate their own data before AI development can begin.

Schrödinger sells physics-based simulation software and collaborates on drug programs using computational chemistry. Its tools are widely licensed to pharma, offering predictable subscription pricing. In contrast to Algen Biotechnologies’ gene-modulation focus, Schrödinger excels at structure-based design and molecular dynamics but does not generate the functional genomic datasets central to AlgenBrain.

Teladoc Health operates a large virtual-care platform focused on on-demand video visits and chronic-care programs. Its strength lies in 24/7 access and employer contracts, yet it lacks Akido Labs emphasis on multiplying in-person slots or operating its own multi-site medical group. Pricing is typically subscription or per-visit through payers, making it cheaper for purely remote needs but less relevant when the goal is same-day house calls or zero-copay in-person expansion.

Recursion Pharmaceuticals runs one of the largest automated wet-lab-plus-AI platforms, generating millions of cellular images to map disease biology. Its strength lies in scale of phenotypic screening and an advancing clinical pipeline. Compared with Algen Biotechnologies, Recursion is less focused on CRISPR gene modulation and more on high-content imaging; both companies pursue big-pharma partnerships but Recursion is already public with broader disease coverage.

Flywheel provides an enterprise imaging data platform that orchestrates curation, de-identification, and machine-learning workflows across radiology and pathology. Strengths include on-prem/cloud deployment flexibility and strong audit trails for clinical trials. Compared with Segmed, Flywheel offers deeper workflow tooling but generally smaller pre-curated regulatory-grade cohorts and less emphasis on multi-manufacturer longitudinal studies for immediate FDA validation use cases.

Oscar Health combines insurance with a tech layer for member navigation and virtual care. It offers transparent pricing and app-based experiences but remains payer-centric and does not run the provider-dense, AI-augmented in-person model Akido Labs uses to drive copay elimination and next-day access.

Philips HealthSuite aggregates imaging and patient-generated data across its hardware ecosystem with built-in analytics. Strengths include seamless modality integration. Against Segmed it is more hardware-tied, offers fewer third-party manufacturer studies, and targets hospital networks rather than external AI developers seeking broad de-identified research datasets.

Recursion Pharmaceuticals runs one of the largest automated wet-lab-plus-AI platforms, generating millions of cellular images to map disease biology. Its strength lies in scale of phenotypic screening and an advancing clinical pipeline. Compared with Algen Biotechnologies, Recursion is less focused on CRISPR gene modulation and more on high-content imaging; both companies pursue big-pharma partnerships but Recursion is already public with broader disease coverage.

Flywheel provides an enterprise imaging data platform that orchestrates curation, de-identification, and machine-learning workflows across radiology and pathology. Strengths include on-prem/cloud deployment flexibility and strong audit trails for clinical trials. Compared with Segmed, Flywheel offers deeper workflow tooling but generally smaller pre-curated regulatory-grade cohorts and less emphasis on multi-manufacturer longitudinal studies for immediate FDA validation use cases.